Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Brooks Jackson
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Disorders
Chemicals & Drugs
Geographic Areas
Physiology
Concepts & Ideas
Procedures
Phenomena
Sign-in to see full Profile
Network (preview)
48
Guay, Laura
44
Mmiro, Francis
42
Eshleman, Susan
30
Musoke, Philippa
14
Mwatha, Anthony
14
Ndugwa, Christopher
13
Fowler, Mary Glenn
13
Kataaha, Peter
10
Becker-Pergola, Graziella
9
Church, Jessica
9
Kumwenda, Newton
9
Nakabiito, Clemensia
9
Taha, Taha
8
Chen, Shu
8
Balfour, Henry
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Brooks Jackson (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Shiu Carlum; Cunningham Coleen K; Greenough Thomas; Muresan Petronella; Sanchez-Merino Victor; Carey Vincent; Jackson J Brooks; Ziemniak Carrie; Fox Lawrence; Belzer Marvin; Ray Stuart C; Luzuriaga Katherine; Persaud Deborah;
Identification of ongoing human immunodeficiency virus type 1 (HIV-1) replication in residual viremia during recombinant HIV-1 poxvirus immunizations in patients with clinically undetectable viral loads on durable suppressive highly active antiretroviral therapy.
Journal of virology 2009;83(19):9731-42.
-
2009: Mmiro Francis A; Aizire Jim; Mwatha Anthony K; Eshleman Susan H; Donnell Deborah; Fowler Mary Glenn; Nakabiito Clemensia; Musoke Philippa M; Jackson J Brooks; Guay Laura A
Predictors of early and late mother-to-child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala, Uganda.
Journal of acquired immune deficiency syndromes (1999) 2009;52(1):32-9.
-
2009: Huang Wei; Eshleman Susan H; Toma Jonathan; Stawiski Eric; Whitcomb Jeannette M; Jackson J Brooks; Guay Laura; Musoke Philippa; Parkin Neil; Petropoulos Christos J
Vertical transmission of X4-tropic and dual-tropic HIV-1 in five Ugandan mother-infant pairs.
AIDS (London, England) 2009;23(14):1903-8.
-
2009: Jackson J Brooks; Dick James; Tekle Tsigereda; Simmons Antoine; Carroll Karen C
Lack of antimicrobial activity by the antiretroviral drug nevirapine against common bacterial pathogens.
Antimicrobial agents and chemotherapy 2009;53(8):3606-7.
-
2009: Church Jessica D; Huang Wei; Parkin Neil; Marlowe Natalia; Guay Laura A; Omer Saad B; Musoke Philippa; Jackson J Brooks; Eshleman Susan H
Comparison of laboratory methods for analysis of non-nucleoside reverse transcriptase inhibitor resistance in Ugandan infants.
AIDS research and human retroviruses 2009;25(7):657-63.
-
2009: Church Jessica D; Mwatha Anthony; Bagenda Danstan; Omer Saad B; Donnell Deborah; Musoke Philippa; Nakabiito Clemensia; Eure Chineta; Bakaki Paul; Matovu Flavia; Thigpen Michael C; Guay Laura A; McConnell Michelle; Fowler Mary Glenn; Jackson J Brooks; Eshleman Susan H
In utero HIV infection is associated with an increased risk of nevirapine resistance in ugandan infants who were exposed to perinatal single dose nevirapine.
AIDS research and human retroviruses 2009;25(7):673-7.
-
2009: Hudelson Sarah E; Marlowe Natalia; Huang Wei; Bruce Robert; Church Jessica D; Husnik Marla; Donnell Deborah; Coates Thomas; Jackson J Brooks; Chesney Margaret; Koblin Beryl; Eshleman Susan H
Analysis of HIV type 1 gp41 and enfuvirtide susceptibility among men in the United States who were HIV infected prior to availability of HIV entry inhibitors.
AIDS research and human retroviruses 2009;25(7):701-5.
-
2008: Singh Kumud K; Hughes Michael D; Chen Jie; Phiri Kelesitse; Rousseau Christine; Kuhn Louise; Coutsoudis Anna; Jackson J Brooks; Guay Laura A; Musoke Philippa; Mmiro Francis; Semba Richard D; Spector Stephen A
Associations of chemokine receptor polymorphisms With HIV-1 mother-to-child transmission in sub-Saharan Africa: possible modulation of genetic effects by antiretrovirals.
Journal of acquired immune deficiency syndromes (1999) 2008;49(3):259-65.
-
2008: Musoke Philippa M; Young Alicia M; Owor Maxensia A; Lubega Irene R; Brown Elizabeth R; Mmiro Francis A; Mofenson Lynne M; Jackson J Brooks; Fowler Mary Glenn; Guay Laura A
Total lymphocyte count: not a surrogate marker for risk of death in HIV-infected Ugandan children.
Journal of acquired immune deficiency syndromes (1999) 2008;49(2):171-8.
-
2008: Church Jessica D; Omer Saad B; Guay Laura A; Huang Wei; Lidstrom Jessica; Musoke Philippa; Mmiro Francis; Jackson J Brooks; Eshleman Susan H
Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission.
The Journal of infectious diseases 2008;198(7):1075-82.
-
2008: Towler William Ian; Church Jessica D; Eshleman James R; Fowler Mary Glenn; Guay Laura A; Jackson J Brooks; Eshleman Susan H
Analysis of nevirapine resistance mutations in cloned HIV type 1 variants from HIV-infected Ugandan infants using a single-step amplification-sequencing method (AmpliSeq).
AIDS research and human retroviruses 2008;24(9):1209-13.
-
2008: Bedri Abubaker; Gudetta Berhanu; Isehak Abdulhamid; Kumbi Solomon; Lulseged Sileshi; Mengistu Yohannes; Bhore Arvind V; Bhosale Ramesh; Varadhrajan Venkat; Gupte Nikhil; Sastry Jayagowri; Suryavanshi Nishi; Tripathy Srikanth; Mmiro Francis; Mubiru Michael; Onyango Carolyne; Taylor Adrian; Musoke Philippa; Nakabiito Clemensia; Abashawl Aida; Adamu Rahel; Antelman Gretchen; Bollinger Robert C; Bright Patricia; Chaudhary Mohammad A; Coberly Jacqueline; Guay Laura; Fowler Mary Glenn; Gupta Amita; Hassen Elham; Jackson J Brooks; Moulton Lawrence H; Nayak Uma; Omer Saad B; Propper Lidia; Ram Malathi; Rexroad Vivian; Ruff Andrea J; Shankar Anita; Zwerski Sheryl
Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials.
Lancet 2008;372(9635):300-13.
-
2008: Boeke Caroline E; Jackson J Brooks
Estimate of infant HIV-free survival at 6 to 8 weeks of age due to maternal antiretroviral prophylaxis in Sub-Saharan Africa, 2004-2005.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002) 2008;7(3):133-40.
-
2008: Church Jessica D; Huang Wei; Mwatha Anthony; Toma Jonathan; Stawiski Eric; Donnell Deborah; Guay Laura A; Mmiro Francis; Musoke Philippa; Jackson J Brooks; Parkin Neil; Eshleman Susan H
HIV-1 tropism and survival in vertically infected Ugandan infants.
The Journal of infectious diseases 2008;197(10):1382-8.
-
2008: Piwowar-Manning Estelle; Lugalia Lebah; Kafufu Bosco; Jackson J Brooks
Comparison of results obtained with Amplicor HIV-1 DNA PCR test version 1.5 using 100 versus 500 microliters of whole blood.
Journal of clinical microbiology 2008;46(3):1104-5.
-
2008: Boeke Caroline E; Pauly Megan E; Hatch-Stock Holly; Jackson J Brooks
CMV antibody prevalence and seroincidence in plateletpheresis donors.
Journal of clinical apheresis 2008;23(2):63-5.
-
2007: Chou Victoria B; Omer Saad B; Hussain Hamidah; Mugasha Christine; Musisi Maria; Mmiro Francis; Musoke Philippa; Jackson J Brooks; Guay Laura A
The costs associated with adverse event procedures for an international HIV clinical trial determined by activity-based costing.
Journal of acquired immune deficiency syndromes (1999) 2007;46(4):426-32.
-
2007: Flys Tamara S; Mwatha Anthony; Guay Laura A; Nakabiito Clemensia; Donnell Deborah; Musoke Philippa; Mmiro Francis; Jackson J Brooks; Eshleman Susan H
Detection of K103N in Ugandan women after repeated exposure to single dose nevirapine.
AIDS (London, England) 2007;21(15):2077-82.
-
2007: Huang Wei; Eshleman Susan H; Toma Jonathan; Fransen Signe; Stawiski Eric; Paxinos Ellen E; Whitcomb Jeannette M; Young Alicia M; Donnell Deborah; Mmiro Francis; Musoke Philippa; Guay Laura A; Jackson J Brooks; Parkin Neil T; Petropoulos Christos J
Coreceptor tropism in human immunodeficiency virus type 1 subtype D: high prevalence of CXCR4 tropism and heterogeneous composition of viral populations.
Journal of virology 2007;81(15):7885-93.
-
2007: Taube Janis M; Nichols Andrew D; Bornman Lynette S; Bornman Daniel M; Jackson Jay Brooks
Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection.
Journal of cutaneous pathology 2007;34(7):565-70.
-
2007: Taha Taha E; Hoover Donald R; Kumwenda Newton I; Fiscus Susan A; Kafulafula George; Nkhoma Chiwawa; Chen Shu; Piwowar Estelle; Broadhead Robin L; Jackson J Brooks; Miotti Paolo G
Late postnatal transmission of HIV-1 and associated factors.
The Journal of infectious diseases 2007;196(1):10-4.
-
2007: Zhang Yuanzhi; Shan Hua; Trizzino Jennifer; Ruan Yuhua; Beauchamp Geetha; Mâsse Benoît; Ma Jun; Rui Baoling; Wang Jun; Liu Minsheng; Wang Yunxia; He Yixin; Poundstone Katharine; Jiang Yan; Jackson J Brooks; Shao Yiming
HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2007;11(4):318-23.
-
2007: Church Jessica D; Hudelson Sarah E; Guay Laura A; Chen Shu; Hoover Donald R; Parkin Neil; Fiscus Susan A; Mmiro Francis; Musoke Philippa; Kumwenda Newton; Jackson J Brooks; Taha Taha E; Eshleman Susan H
HIV type 1 variants with nevirapine resistance mutations are rarely detected in antiretroviral drug-naive African women with subtypes A, C, and D.
AIDS research and human retroviruses 2007;23(6):764-8.
-
2007: Flys Tamara S; Donnell Deborah; Mwatha Anthony; Nakabiito Clemensia; Musoke Philippa; Mmiro Francis; Jackson J Brooks; Guay Laura A; Eshleman Susan H
Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission.
The Journal of infectious diseases 2007;195(5):711-5.
-
2006: Wei Liu; Chen Jie; Rodolph Michelle; Beauchamp Geetha; Mâsse Ben; Li Rongjian; Wang Shaoping; Ruan Yuhua; Lai Shenghan; Zhang Li; Zhou Feng; Rose Scott M; Perdue Thomas; Lai Shenghan; Shao Yiming; Jackson J Brooks
HIV incidence, retention, and changes of high-risk behaviors among rural injection drug users in Guangxi, China.
Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 2006;27(4):53-61.
-
2006: Liu Wei; Chen Jie; Rodolph Michelle; Beauchamp Geetha; Mâsse Benoît; Wang Shaoping; Li Rongjian; Ruan Yuhua; Zhou Feng; Leung Man-kit; Lai Shenghan; Shao Yiming; Jackson J Brooks
HIV prevalence among injection drug users in rural Guangxi China.
Addiction (Abingdon, England) 2006;101(10):1493-8.
-
2006: Church Jessica D; Jones Dana; Flys Tamara; Hoover Donald; Marlowe Natalia; Chen Shu; Shi Chanjuan; Eshleman James R; Guay Laura A; Jackson J Brooks; Kumwenda Newton; Taha Taha E; Eshleman Susan H
Sensitivity of the ViroSeq HIV-1 genotyping system for detection of the K103N resistance mutation in HIV-1 subtypes A, C, and D.
The Journal of molecular diagnostics : JMD 2006;8(4):430-2; quiz 527.
-
2006: Eshleman Susan H; Church Jessica D; Chen Shu; Guay Laura A; Mwatha Anthony; Fiscus Susan A; Mmiro Francis; Musoke Philippa; Kumwenda Newton; Jackson J Brooks; Taha Taha E; Hoover Donald R
Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):518-21.
-
2006: Flys Tamara S; Chen Shu; Jones Dana C; Hoover Donald R; Church Jessica D; Fiscus Susan A; Mwatha Anthony; Guay Laura A; Mmiro Francis; Musoke Philippa; Kumwenda Newton; Taha Taha E; Jackson J Brooks; Eshleman Susan H
Quantitative analysis of HIV-1 variants with the K103N resistance mutation after single-dose nevirapine in women with HIV-1 subtypes A, C, and D.
Journal of acquired immune deficiency syndromes (1999) 2006;42(5):610-3.
-
2006: Eshleman Susan H; Jones Dana; Galovich Justin; Paxinos Ellen E; Petropoulos Christos J; Jackson J Brooks; Parkin Neil
Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations.
AIDS research and human retroviruses 2006;22(3):289-93.
-
2006: Eshleman Susan H; Hoover Donald R; Hudelson Sarah E; Chen Shu; Fiscus Susan A; Piwowar-Manning Estelle; Jackson J Brooks; Kumwenda Newton I; Taha Taha E
Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.
The Journal of infectious diseases 2006;193(4):479-81.
-
2006: Jackson J Brooks; Parsons Teresa; Musoke Philippa; Nakabiito Clemensia; Donnell Deborah; Fleming Thomas; Mirochnick Mark; Mofenson Lynne; Fowler Mary Glenn; Mmiro Francis; Guay Laura
Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
AIDS (London, England) 2006;20(2):217-22.
-
2005: Eshleman Susan H; Hoover Donald R; Chen Shu; Hudelson Sarah E; Guay Laura A; Mwatha Anthony; Fiscus Susan A; Mmiro Francis; Musoke Philippa; Jackson J Brooks; Kumwenda Newton; Taha Taha
Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.
AIDS (London, England) 2005;19(18):2167-9.
-
2005: Eshleman Susan H; Guay Laura A; Wang Jing; Mwatha Anthony; Brown Elizabeth R; Musoke Philippa; Mmiro Francis; Jackson J Brooks
Distinct patterns of emergence and fading of K103N and Y181C in women with subtype A vs. D after single-dose nevirapine: HIVNET 012.
Journal of acquired immune deficiency syndromes (1999) 2005;40(1):24-9.
-
2005: Eshleman Susan H; Guay Laura A; Mwatha Anthony; Brown Elizabeth; Musoke Philippa; Mmiro Francis; Jackson J Brooks
Comparison of mother-to-child transmission rates in Ugandan women with subtype A versus D HIV-1 who received single-dose nevirapine prophylaxis: HIV Network For Prevention Trials 012.
Journal of acquired immune deficiency syndromes (1999) 2005;39(5):593-7.
-
2005: Eshleman Susan H; Hoover Donald R; Chen Shu; Hudelson Sarah E; Guay Laura A; Mwatha Anthony; Fiscus Susan A; Mmiro Francis; Musoke Philippa; Jackson J Brooks; Kumwenda Newton; Taha Taha
Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP.
The Journal of infectious diseases 2005;192(1):30-6.
-
2005: Flys Tamara; Nissley Dwight V; Claasen Cassidy W; Jones Dana; Shi Chanjuan; Guay Laura A; Musoke Philippa; Mmiro Francis; Strathern Jeffrey N; Jackson J Brooks; Eshleman James R; Eshleman Susan H
Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.
The Journal of infectious diseases 2005;192(1):24-9.
-
2005: Jones Dana; Parkin Neil; Hudelson Sarah E; Guay Laura A; Musoke Philippa; Mmiro Francis; Jackson J Brooks; Eshleman Susan H
Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
AIDS research and human retroviruses 2005;21(4):319-24.
-
2005: Cressey Tim R; Jourdain Gonzague; Lallemant Marc J; Kunkeaw Suparat; Jackson J Brooks; Musoke Philippa; Capparelli Edmund; Mirochnick Mark
Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother-to-child transmission of HIV-1.
Journal of acquired immune deficiency syndromes (1999) 2005;38(3):283-8.
-
2005: Semba Richard D; Ndugwa Christopher; Perry Robert T; Clark Tamara D; Jackson J Brooks; Melikian George; Tielsch James; Mmiro Francis
Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: A controlled clinical trial.
Nutrition (Burbank, Los Angeles County, Calif.) 2005;21(1):25-31.
-
2004: Marlowe Natalia; Flys Tamara; Hackett John; Schumaker Michael; Jackson J Brooks; Eshleman Susan H;
Analysis of insertions and deletions in the gag p6 region of diverse HIV type 1 strains.
AIDS research and human retroviruses 2004;20(10):1119-25.
-
2004: Hendrix Craig W; Collier Ann C; Lederman Michael M; Schols Dominique; Pollard Richard B; Brown Stephen; Jackson J Brooks; Coombs Robert W; Glesby Marshall J; Flexner Charles W; Bridger Gary J; Badel Karin; MacFarland Ronald T; Henson Geoffrey W; Calandra Gary;
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1253-62.
-
2004: Eshleman S H; Guay L A; Mwatha A; Cunningham S P; Brown E R; Musoke P; Mmiro F; Jackson J B
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012.
AIDS research and human retroviruses 2004;20(6):595-9.
-
2004: Jackson J Brooks; Piwowar-Manning Estelle; Johnson-Lewis LeTanya; Bassett Roland; Demeter Lisa M; Brambilla Donald
Comparison of versions 1.0 AND 1.5 of the UltraSensitive AMPLICOR HIV-1 MONITOR test for subjects with low viral load.
Journal of clinical microbiology 2004;42(6):2774-6.
-
2004: Coutsoudis Anna; Dabis Francois; Fawzi Wafaie; Gaillard Philippe; Haverkamp Geert; Harris D Robert; Jackson J Brooks; Leroy Valerie; Meda Nicolas; Msellati Philippe; Newell Marie-Louise; Nsuati Ruth; Read Jennifer S; Wiktor Stefan
Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis.
The Journal of infectious diseases 2004;189(12):2154-66.
-
2004: Eshleman Susan H; Guay Laura A; Mwatha Anthony; Brown Elizabeth R; Cunningham Shawn P; Musoke Philippa; Mmiro Francis; Jackson J Brooks
Characterization of nevirapine resistance mutations in women with subtype A vs. D HIV-1 6-8 weeks after single-dose nevirapine (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2004;35(2):126-30.
-
2003: Jacobson Jeffrey M; Lederman Michael M; Spritzler John; Valdez Hernan; Tebas Pablo; Skowron Gail; Wang Rui; Jackson J Brooks; Fox Lawrence; Landay Alan; Gilbert Mark J; O'Neil Dorothy; Bancroft Lynne; Al-Harthi Lena; Jacobson Mark A; Merigan Thomas C; Glesby Marshall J;
Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
The Journal of infectious diseases 2003;188(12):1804-14.
-
2003: Eshleman Susan H; Jones Dana; Flys Tamara; Petrauskene Olga; Jackson J Brooks
Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System.
BioTechniques 2003;35(3):614-8, 620, 622.
-
2003: Jackson J Brooks; Musoke Philippa; Fleming Thomas; Guay Laura A; Bagenda Danstan; Allen Melissa; Nakabiito Clemensia; Sherman Joseph; Bakaki Paul; Owor Maxensia; Ducar Constance; Deseyve Martina; Mwatha Anthony; Emel Lynda; Duefield Corey; Mirochnick Mark; Fowler Mary Glenn; Mofenson Lynne; Miotti Paolo; Gigliotti Maria; Bray Dorothy; Mmiro Francis
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Lancet 2003;362(9387):859-68.
-
2003: Piwowar-Manning Estelle M; Henderson Terry A; Brisbin Lorraine; Jackson J Brooks
A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter.
American journal of clinical pathology 2003;120(2):268-70.
-
2003: Brambilla Don; Jennings Cheryl; Aldrovandi Grace; Bremer James; Comeau Anne Marie; Cassol Sharon A; Dickover Ruth; Jackson J Brooks; Pitt Jane; Sullivan John L; Butcher Ann; Grosso Lynell; Reichelderfer Patricia; Fiscus Susan A
Multicenter evaluation of use of dried blood and plasma spot specimens in quantitative assays for human immunodeficiency virus RNA: measurement, precision, and RNA stability.
Journal of clinical microbiology 2003;41(5):1888-93.
-
2003: Jackson J Brooks; Barnett Scott; Piwowar-Manning Estelle; Apuzzo Linda; Raines Charles; Hendrix Craig; Hamzeh Fayez; Gallant Joel
A phase I/II study of nevirapine for pre-exposure prophylaxis of HIV-1 transmission in uninfected subjects at high risk.
AIDS (London, England) 2003;17(4):547-53.
-
2002: Eshleman Susan H; Guay Laura A; Fleming Thomas; Mwatha Anthony; Mracna Martin; Becker-Pergola Graziella; Musoke Philippa; Mmiro Francis; Jackson J Brooks
Survival of Ugandan infants with subtype A and D HIV-1 infection (HIVNET 012).
Journal of acquired immune deficiency syndromes (1999) 2002;31(3):327-30.
-
2002: Keating Sheila M; Bollinger Robert C; Quinn Thomas C; Jackson J Brooks; Carruth Lucy M
Cross-clade T lymphocyte-mediated immunity to HIV type 1: implications for vaccine design and immunodetection assays.
AIDS research and human retroviruses 2002;18(14):1067-79.
-
2002: Kumwenda Newton; Miotti Paolo G; Taha Taha E; Broadhead Robin; Biggar Robert J; Jackson J Brooks; Melikian George; Semba Richard D
Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;35(5):618-24.
-
2002: Vargo Janet; Smith Katie; Knott Caroline; Wang Songbai; Fang Chyang; McDonough Sherrol; Giachetti Cristina; Caglioti Sally; Gammon Richard; Gilbert Denise; Jackson J Brooks; Richards William; Stramer Susan; Mimms Larry
Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
Transfusion 2002;42(7):876-85.
-
2002: Klevytska Alexandra M; Mracna Martin R; Guay Laura; Becker-Pergola Graziella; Furtado Manohar; Zhang Linqi; Jackson J Brooks; Eshleman Susan H
Analysis of length variation in the V1-V2 region of env in nonsubtype B HIV type 1 from Uganda.
AIDS research and human retroviruses 2002;18(11):791-6.
-
2002: Guay Laura A; Musoke Philippa; Hom David L; Nakabiito Clemensia; Bagenda Danstan; Fletcher Courtney V; Marum Lawrence H; Fowler Mary Glenn; Falksveden Lars G; Wahren Britta; Kataaha Peter; Wigzell Hans; Mmiro Francis A; Jackson J Brooks
Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda.
AIDS (London, England) 2002;16(10):1391-400.
-
2002: Jackson J B; Smith K; Knott C; Korpela A; Simmons A; Piwowar-Manning E; McDonough S; Mimms L; Vargo J M
Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population.
Journal of clinical microbiology 2002;40(7):2387-91.
-
2002: Demeter Lisa M; Bosch Ronald J; Coombs Robert W; Fiscus Susan; Bremer James; Johnson Victoria A; Erice Alejo; Jackson J Brooks; Spector Stephen A; Squires Kathleen M; Fischl Margaret A; Hughes Michael D; Hammer Scott M
Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.
Journal of clinical microbiology 2002;40(6):2089-94.
-
2002: Eshleman Susan H; Gonzales Matthew J; Becker-Pergola Graziella; Cunningham Shawn C; Guay Laura A; Jackson J Brooks; Shafer Robert W
Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D.
AIDS research and human retroviruses 2002;18(7):507-11.
-
2002: Eshleman Susan H; Jackson J Brooks
Nevirapine resistance after single dose prophylaxis.
AIDS reviews 2002;4(2):59-63.
-
2002: Krogstad Paul; Eshleman Susan H; Geng Yongzhi; Jackson J Brooks; Wantman Michael; Korber Bette; Lang Dorothy; Wiznia Andrew; Johnson George; Nachman Sharon; Palumbo Paul
Mother-to-child transmission in the United States of subtypes D and A/G human immunodeficiency virus type 1.
AIDS research and human retroviruses 2002;18(6):413-7.
-
2002: Krogstad Paul; Lee Sophia; Johnson George; Stanley Kenneth; McNamara James; Moye John; Jackson J Brooks; Aguayo Rosaura; Dieudonne Arry; Khoury Margaret; Mendez Hermann; Nachman Sharon; Wiznia Andrew;
Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(7):991-1001.
-
2002: Clark T D; Mmiro F; Ndugwa C; Perry R T; Jackson J B; Melikian G; Semba R D
Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda.
Annals of tropical paediatrics 2002;22(1):11-7.
-
2002: Totin Dana; Ndugwa Christopher; Mmiro Francis; Perry Robert T; Jackson J Brooks; Semba Richard D
Iron deficiency anemia is highly prevalent among human immunodeficiency virus-infected and uninfected infants in Uganda.
The Journal of nutrition 2002;132(3):423-9.
-
2001: Demeter L M; Hughes M D; Coombs R W; Jackson J B; Grimes J M; Bosch R J; Fiscus S A; Spector S A; Squires K E; Fischl M A; Hammer S M
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320.
Annals of internal medicine 2001;135(11):954-64.
-
2001: Mracna M; Becker-Pergola G; Dileanis J; Guay L A; Cunningham S; Jackson J B; Eshleman S H
Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda.
Journal of clinical microbiology 2001;39(12):4323-7.
-
2001: Eshleman S H; Mracna M; Guay L A; Deseyve M; Cunningham S; Mirochnick M; Musoke P; Fleming T; Glenn Fowler M; Mofenson L M; Mmiro F; Jackson J B
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
AIDS (London, England) 2001;15(15):1951-7.
-
2001: Eshleman S H; Becker-Pergola G; Deseyve M; Guay L A; Mracna M; Fleming T; Cunningham S; Musoke P; Mmiro F; Jackson J B
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
The Journal of infectious diseases 2001;184(7):914-7.
-
2001: Melikian G; Mmiro F; Ndugwa C; Perry R; Jackson J B; Garrett E; Tielsch J; Semba R D
Relation of vitamin A and carotenoid status to growth failure and mortality among Ugandan infants with human immunodeficiency virus.
Nutrition (Burbank, Los Angeles County, Calif.) 2001;17(7-8):567-72.
-
2001: Eshleman S H; Krogstad P; Jackson J B; Wang Y G; Lee S; Wei L J; Cunningham S; Wantman M; Wiznia A; Johnson G; Nachman S; Palumbo P
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377).
The Journal of infectious diseases 2001;183(12):1732-8.
-
2001: Cunningham S; Ank B; Lewis D; Lu W; Wantman M; Dileanis J A; Jackson J B; Palumbo P; Krogstad P; Eshleman S H
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples.
Journal of clinical microbiology 2001;39(4):1254-7.
-
2001: Jacobson J M; Greenspan J S; Spritzler J; Fox L; Fahey J L; Jackson J B; Chernoff M; Wohl D A; Pulvirenti J J; Hooton T M; Shikuma C
Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
The Journal of infectious diseases 2001;183(2):343-346.
-
2000: Raines C P; Flexner C; Sun E; Heath-Chiozzi M; Lewis R H; Fields C; Deetz C; Apuzzo L; Eshleman S H; Jackson J B; Gallant J E
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks.
Journal of acquired immune deficiency syndromes (1999) 2000;25(4):322-8.
-
2000: Guay L A; Hom D L; Kabengera S R; Piwowar-Manning E M; Kataaha P; Ndugwa C; Marum L H; Kalyesubula I; Jackson J B
HIV-1 ICD p24 antigen detection in ugandan infants: use in early diagnosis of infection and as a marker of disease progression.
Journal of medical virology 2000;62(4):426-34.
-
2000: Marseille E; Kahn J G; Mmiro F; Guay L; Musoke P; Fowler M G; Jackson J B
The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa.
Annals of the New York Academy of Sciences 2000;918():53-6.
-
2000: Wiznia A; Stanley K; Krogstad P; Johnson G; Lee S; McNamara J; Moye J; Jackson J B; Mendez H; Aguayo R; Dieudonne A; Kovacs A; Bamji M; Abrams E; Rana S; Sever J; Nachman S
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team.
AIDS research and human retroviruses 2000;16(12):1113-21.
-
2000: Becker-Pergola G; Mellquist J L; Guay L; Mmiro F; Ndugwa C; Kataaha P; Jackson J B; Eshleman S H
Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women.
AIDS research and human retroviruses 2000;16(12):1099-104.
-
2000: Erice A; Brambilla D; Bremer J; Jackson J B; Kokka R; Yen-Lieberman B; Coombs R W
Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
Journal of clinical microbiology 2000;38(8):2837-45.
-
2000: Jackson J B; Becker-Pergola G; Guay L A; Musoke P; Mracna M; Fowler M G; Mofenson L M; Mirochnick M; Mmiro F; Eshleman S H
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
AIDS (London, England) 2000;14(11):F111-5.
-
2000: Becker-Pergola G; Kataaha P; Johnston-Dow L; Fung S; Jackson J B; Eshleman S H
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults.
AIDS research and human retroviruses 2000;16(8):807-13.
-
2000: Kim S; Hughes M D; Hammer S M; Jackson J B; DeGruttola V; Katzenstein D A
Both serum HIV type 1 RNA levels and CD4+ lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4+ cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
AIDS research and human retroviruses 2000;16(7):645-53.
-
1999: Becker-Pergola G; Mellquist J L; Eshleman J R; Jackson J B; Eshleman S H
Improved detection of human immunodeficiency virus type 1 variants by analysis of replicate amplification reactions: relevance to studies of human immunodeficiency virus type 1 vertical transmission.
Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology 1999;4(4):261-8.
-
1999: Marseille E; Kahn J G; Mmiro F; Guay L; Musoke P; Fowler M G; Jackson J B
Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
Lancet 1999;354(9181):803-9.
-
1999: Guay L A; Musoke P; Fleming T; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Ducar C; Deseyve M; Emel L; Mirochnick M; Fowler M G; Mofenson L; Miotti P; Dransfield K; Bray D; Mmiro F; Jackson J B
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
Lancet 1999;354(9181):795-802.
-
1999: Jacobson J M; Spritzler J; Fox L; Fahey J L; Jackson J B; Chernoff M; Wohl D A; Wu A W; Hooton T M; Sha B E; Shikuma C M; MacPhail L A; Simpson D M; Trapnell C B; Basgoz N
Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
The Journal of infectious diseases 1999;180(1):61-7.
-
1999: Jabs D A; Forman M; Enger C; Jackson J B
Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.
Journal of clinical microbiology 1999;37(5):1431-5.
-
1999: Musoke P; Guay L A; Bagenda D; Mirochnick M; Nakabiito C; Fleming T; Elliott T; Horton S; Dransfield K; Pav J W; Murarka A; Allen M; Fowler M G; Mofenson L; Hom D; Mmiro F; Jackson J B
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
AIDS (London, England) 1999;13(4):479-86.
-
1999: Mellquist J L; Becker-Pergola G; Gu J; Guay L; Himes L; Kataaha P; Mmiro F; Ndugwa C; Jackson J B; Eshleman S H
Dual transmission of subtype A and D HIV type 1 viruses from a Ugandan woman to her infant.
AIDS research and human retroviruses 1999;15(2):217-21.
-
1998: Mellquist J L; Bowman B; Kasturi L; Guay L; Kataaha P; Mmiro F; Ndugwa C; Jackson J B; Eshleman S H
Characterization of HIV type 1 gp120 V3 region sequences from Ugandan infants.
AIDS research and human retroviruses 1998;14(15):1391-5.
-
1998: Lathey J L; Hughes M D; Fiscus S A; Pi T; Jackson J B; Rasheed S; Elbeik T; Reichman R; Japour A; D'Aquila R T; Scott W; Griffith B P; Hammer S M; Katzenstein D A
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team.
The Journal of infectious diseases 1998;177(3):617-24.
-
1997: Brennan C A; Lund J K; Golden A; Yamaguchi J; Vallari A S; Phillips J F; Kataaha P K; Jackson J B; Devare S G
Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
AIDS (London, England) 1997;11(15):1823-32.
-
1997: Jacobson J M; Greenspan J S; Spritzler J; Ketter N; Fahey J L; Jackson J B; Fox L; Chernoff M; Wu A W; MacPhail L A; Vasquez G J; Wohl D A
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
The New England journal of medicine 1997;336(21):1487-93.
-
1997: Jackson J B; Parsons J S; Nichols L S; Knoble N; Kennedy S; Piwowar E M
Detection of human immunodeficiency virus type 1 (HIV-1) antibody by western blotting and HIV-1 DNA by PCR in patients with AIDS.
Journal of clinical microbiology 1997;35(5):1118-21.
-
1997: Jackson J B; Piwowar E M; Parsons J; Kataaha P; Bihibwa G; Onecan J; Kabengera S; Kennedy S D; Butcher A
Detection of human immunodeficiency virus type 1 (HIV-1) DNA and RNA sequences in HIV-1 antibody-positive blood donors in Uganda by the Roche AMPLICOR assay.
Journal of clinical microbiology 1997;35(4):873-6.
-
1997: Jackson J B
Human immunodeficiency virus-indeterminate western blot and abortive infection.
Transfusion 1997;37(1):1-2.
-
1996: Wallis R S; Nsubuga P; Whalen C; Mugerwa R D; Okwera A; Oette D; Jackson J B; Johnson J L; Ellner J J
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial.
The Journal of infectious diseases 1996;174(4):727-33.
-
1996: Coombs R W; Welles S L; Hooper C; Reichelderfer P S; D'Aquila R T; Japour A J; Johnson V A; Kuritzkes D R; Richman D D; Kwok S; Todd J; Jackson J B; DeGruttola V; Crumpacker C S; Kahn J
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working Groups.
The Journal of infectious diseases 1996;174(4):704-12.
-
1996: Welles S L; Jackson J B; Yen-Lieberman B; Demeter L; Japour A J; Smeaton L M; Johnson V A; Kuritzkes D R; D'Aquila R T; Reichelderfer P A; Richman D D; Reichman R; Fischl M; Dolin R; Coombs R W; Kahn J O; McLaren C; Todd J; Kwok S; Crumpacker C S
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team.
The Journal of infectious diseases 1996;174(4):696-703.
-
1996: Katzenstein D A; Hammer S M; Hughes M D; Gundacker H; Jackson J B; Fiscus S; Rasheed S; Elbeik T; Reichman R; Japour A; Merigan T C; Hirsch M S
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team.
The New England journal of medicine 1996;335(15):1091-8.
-
1996: Guay L A; Hom D L; Mmiro F; Piwowar E M; Kabengera S; Parsons J; Ndugwa C; Marum L; Olness K; Kataaha P; Jackson J B
Detection of human immunodeficiency virus type 1 (HIV-1) DNA and p24 antigen in breast milk of HIV-1-infected Ugandan women and vertical transmission.
Pediatrics 1996;98(3 Pt 1):438-44.
-
1996: Jackson J B; Hom D; Piwowar E; Ndugwa C; Kataaha P; Marum L; Guay L; Parsons J; Olness K; Mmiro F
Maternal HIV-1 RNA serum levels at delivery and vertical transmission in Uganda.
Pediatric AIDS and HIV infection 1996;7(1):37-42.
-
1995: Jackson J B
Acute decrease in HIV-1 viral load after initiation of zidovudine therapy: implications for interrupting vertical transmission.
Pediatric AIDS and HIV infection 1995;6(6):358-9.
-
1995: Lederman M M; Jackson J B; Kroner B L; White G C; Eyster M E; Aledort L M; Hilgartner M W; Kessler C M; Cohen A R; Kiger K P
Human immunodeficiency virus (HIV) type 1 infection status and in vitro susceptibility to HIV infection among high-risk HIV-1-seronegative hemophiliacs.
The Journal of infectious diseases 1995;172(1):228-31.
-
1995: Holodniy M; Mole L; Yen-Lieberman B; Margolis D; Starkey C; Carroll R; Spahlinger T; Todd J; Jackson J B
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes.
Journal of clinical microbiology 1995;33(6):1562-6.
-
1995: Jackson J B; Hanson M R; Johnson G M; Spahlinger T G; Polesky H F; Bowman R J
Long-term follow-up of blood donors with indeterminate human immunodeficiency virus type 1 results on Western blot.
Transfusion 1995;35(2):98-102.
-
1994: Reichelderfer P S; Jackson J B
Quality assurance and use of PCR in clinical trials.
PCR methods and applications 1994;4(3):S141-9.
-
1994: Toltzis P; Marx C M; Balfour H H; Jackson J B
Use of semiquantitative human immunodeficiency virus type 1 culture to guide therapy in a premature infant.
American journal of clinical pathology 1994;101(6):753-5.
-
1994: Kalayjian R C; Skowron G; Emgushov R T; Chance M; Spell S A; Borum P R; Webb L S; Mayer K H; Jackson J B; Yen-Lieberman B
A phase I/II trial of intravenous L-2-oxothiazolidine-4-carboxylic acid (procysteine) in asymptomatic HIV-infected subjects.
Journal of acquired immune deficiency syndromes 1994;7(4):369-74.
-
1994: McNamara J G; Rogers M; Goldenthal K; Jackson J B; Rossi P; Fenton T; Fast P E
Conference on advances in AIDS vaccine development--1993. Report of Perinatal Intervention Working Group.
AIDS research and human retroviruses 1994;10 Suppl 2():S161-4.
-
1993: Jackson J B; Drew J; Lin H J; Otto P; Bremer J W; Hollinger F B; Wolinsky S M
Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories.
Journal of clinical microbiology 1993;31(12):3123-8.
-
1993: Jackson J B; Kataaha P; Hom D L; Mmiro F; Guay L; Ndugwa C; Marum L; Piwowar E; Brewer K; Toedter G
Beta 2-microglobulin, HIV-1 p24 antibody and acid-dissociated HIV-1 p24 antigen levels: predictive markers for vertical transmission of HIV-1 in pregnant Ugandan women.
AIDS (London, England) 1993;7(11):1475-9.
-
1993: Jackson J B
Detection and quantitation of human immunodeficiency virus type 1 using molecular DNA/RNA technology.
Archives of pathology & laboratory medicine 1993;117(5):473-7.
-
1992: Henrard D R; Phillips J; Burchett S; Jackson J B; Kataaha P; Mmiro F; Ndugwa C
Plasma viral load in symptom-free women and vertical transmission of HIV-1.
Lancet 1992;340(8833):1470-1.
-
1992: Jackson J B
Human immunodeficiency virus (HIV)-indeterminate western blots and latent HIV infection.
Transfusion 1992;32(6):497-9.
-
1991: Jackson J B; Ndugwa C; Mmiro F; Kataaha P; Guay L; Dragon E A; Goldfarb J; Olness K
Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants.
AIDS (London, England) 1991;5(12):1463-7.
-
1991: Conover P T; Fang C T; Lam E; Hirschler N V; Jackson J B; Yomtovian R A
Antibodies to hepatitis C virus in autologous blood donors.
Transfusion 1991;31(7):616-9.
-
1991: Jackson J B; Guay L; Goldfarb J; Olness K; Ndugwa C; Mmiro F; Kataaha P; Allain J P
Hepatitis C virus antibody in HIV-1 infected Ugandan mothers.
Lancet 1991;337(8740):551.
-
1990: Jackson J B
Human immunodeficiency virus type 1 antigen and culture assays.
Archives of pathology & laboratory medicine 1990;114(3):249-53.
-
1990: Jackson J B
The polymerase chain reaction in transfusion medicine.
Transfusion 1990;30(1):51-7.
-
1990: Jackson J B; MacDonald K L; Cadwell J; Sullivan C; Kline W E; Hanson M; Sannerud K J; Stramer S L; Fildes N J; Kwok S Y
Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.
The New England journal of medicine 1990;322(4):217-22.
-
1990: Jackson J B; Kwok S Y; Sninsky J J; Hopsicker J S; Sannerud K J; Rhame F S; Henry K; Simpson M; Balfour H H
Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals.
Journal of clinical microbiology 1990;28(1):16-9.
-
1989: MacDonald K L; Jackson J B; Bowman R J; Polesky H F; Rhame F S; Balfour H H; Osterholm M T
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications.
Annals of internal medicine 1989;110(8):617-21.
-
1989: Jackson J B; Kwok S Y; Hopsicker J S; Sannerud K J; Sninsky J J; Edson J R; Balfour H H
Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs.
Transfusion 1989;29(3):265-7.
-
1989: Jackson J B; Sannerud K J; Balfour H H
Comparison of two serum HIV antigen assays for selection of asymptomatic antigenemic individuals into clinical trials.
Journal of acquired immune deficiency syndromes 1989;2(4):394-7.
-
1988: Jackson J B; Sannerud K J; Hopsicker J S; Kwok S Y; Edson J R; Balfour H H
Hemophiliacs with HIV antibody are actively infected.
JAMA : the journal of the American Medical Association 1988;260(15):2236-9.
-
1988: Jackson J B; Coombs R W; Sannerud K; Rhame F S; Balfour H H
Rapid and sensitive viral culture method for human immunodeficiency virus type 1.
Journal of clinical microbiology 1988;26(7):1416-8.
-
1988: Jackson J B; Sannerud K; Rhame F S; Balfour H H
Evaluation of two commercial tests for human immunodeficiency virus antigens in culture supernatant fluid.
American journal of clinical pathology 1988;89(6):788-90.
-
1988: Jackson J B; Erice A; Englund J A; Edson J R; Balfour H H
Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1.
Transfusion 1988;28(2):187-9.
-
1988: Jackson J B; Balfour H H
Practical diagnostic testing for human immunodeficiency virus.
Clinical microbiology reviews 1988;1(1):124-38.
-
1987: Jackson J B; Orr H T; McCullough J J; Jordan M C
Failure to detect human cytomegalovirus DNA in IgM-seropositive blood donors by spot hybridization.
The Journal of infectious diseases 1987;156(6):1013-6.
Sign-in to see more
